K. Bremer

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Michael Herold, Antina Schulze, Dietger Niederwieser et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 103 citations · Full text

Lymphoid Neoplasia, Oncology, Mantle Cell Lymphoma +8

A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: Assessment of efficacy, safety and patient preference

Adam Noble, K. Bremer, L. Goedhals et al. · European Journal of Cancer · 1994 · 61 citations

Medicine, Cancer Management, Pharmacology +7

Impaired recirculation of b lymphocytes in chronic lymphocytic leukemia

H.-D. Flad, Christian G. Huber, K. Bremer et al. · European Journal of Immunology · 1973 · 34 citations

Immunohematology, Lymphocyte Development, Immune Regulation +19

Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors

K. Bremer, N. Niederle, W. Krischke et al. · Cancer Treatment Reviews · 1982 · 28 citations

Andrology, Etoposide-ifosfamide Therapy, Medicine +3

[Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].

G Brittinger, H. Bartels, K. Bremer et al. · PubMed · 1977 · 28 citations

Hematological Malignancy, Lymphoid Neoplasia, Tumoral Pathology +15